Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes.

Nakamura, Kazuo; Yamagishi, Sho-ichi; Adachi, Hisashi; Kurita-Nakamura, Yayoi; Matsui, Takanori; Yoshida, Takafumi; Imaizumi, Tsutomu

Nakamura, Kazuo; Yamagishi, Sho-ichi; Adachi, Hisashi; Kurita-Nakamura, Yayoi; Matsui, Takanori; Yoshida, Takafumi; Imaizumi, Tsutomu.

Affiliation

Nakamura K; Departments of Medicine, Kurume University School of Medicine, Kurume, Japan.

Mol Med ; 13(3-4): 185-9, 2007.

Article in En | MEDLINE | ID: mdl-17592553

Subject(s)

Diabetes Mellitus, Type 2/blood; Inflammation/blood; Receptors, Immunologic/blood; Aged; Biomarkers/blood; Chemokine CCL2/blood; Cross-Sectional Studies; Female; Humans; Japan/epidemiology; Male; Middle Aged; Receptor for Advanced Glycation End Products; Solubility; Tumor Necrosis Factor-alpha/blood

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Immunologic / Diabetes Mellitus, Type 2 / Inflammation Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2007 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google